Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, inhibit https://caoimhegjxp193048.wikicommunications.com/6872626/novel_agents_in_diabetes_management